Retatrutide
Triple incretin receptor agonist
An experimental peptide that acts on three hormone receptors. Researchers studied it in phase 2 trials involving weight and blood sugar.
Plain-English peptide research. Affiliate links are disclosed.Peptides explained in plain English, from published research. Veritide sells nothing; some links to a third-party UK laboratory supplier earn us a commission. Research and educational reference only — not medical advice.
A peptide made of 16 amino acids and encoded by mitochondrial DNA. Researchers studied it mainly in metabolism and exercise models.
Regulatory status: Not licensed as a medicine in the United Kingdom. It holds no MHRA marketing authorisation, has no approved indication, and is not approved for human or animal use.

Cell & tissue research
Research stage: Early cell and animal research, plus observational human studies
The research pathway — not every compound has reached human trials. Illustrations are simplified, not study results.
MOTS-c is produced from genetic information inside mitochondria, the parts of cells that release energy. It belongs to a small group called mitochondrial-derived peptides.
Cell and animal studies suggested that MOTS-c affected AMPK, a system that helps cells respond to low energy, and other pathways involved in metabolism.
Researchers proposed that it helped mitochondria send information about the cell’s energy state to the nucleus.
Research is mostly cells and rodents, where it reported effects on how cells handle energy, blood sugar responses and exercise performance.
Studies that simply observed people found that natural blood levels of the peptide tracked with fitness and metabolic measures — a link, not proof that the peptide caused it.
No completed, well-controlled human trial had been published.
For laboratory research use only. Not a medicine and not for human or animal use.
Veritide does not sell or supply anything. This links to a third-party UK laboratory supplier; we may earn a commission if you buy through it, at no extra cost to you. Materials are sold for laboratory research use only and are not licensed medicines.
Triple incretin receptor agonist
An experimental peptide that acts on three hormone receptors. Researchers studied it in phase 2 trials involving weight and blood sugar.
Dual GLP-1 / glucagon receptor agonist
An experimental peptide based on a natural gut hormone. Researchers studied it mainly in phase 2 and phase 3 trials in China.
Synthetic pentadecapeptide
A laboratory-made peptide made of 15 amino acids. Almost all published research involved cells or rodents rather than people.